vTv Therapeutics Inc. (VTVT) stock price moved -5.05% away from 20-Days Simple Moving Average, 17.65% from 50-Days Simple Moving Average and separated 40.67% from 200 Days Simple Moving Average. vTv Therapeutics Inc. (VTVT) reported loss -4.71% in recent buying and selling session with closing price of $ 2.63. The stock’s traded 0.38 million shares in session while it holds an average volume of 2.33 million shares. The VTVT switched 304.62% away from its 52 week minimum and distanced -65.76% from its 52 week peak. The volatility change in the previous week has observed by 5.10% and experienced of 10.74% change in the last month.
The short ratio in the company’s stock is documented at 0.51 and the short float is around of 44.49%. Beta factor, which measures the riskiness of the security, was registered at -3.62. The Company kept a record of 2.67 million floated shares and 42.78 million shares outstanding. The average true range of the stock is observed at 0.31 and the relative strength index of the stock is recorded at 49.62.
vTv Therapeutics Inc. (VTVT) Stock Profitability Levels:
The company made Return on equity of 10.70% in last 12 months period. Return on assets ratio of the Company was -68.50%. Its return on investment ratio was 34.70% in the trailing 12 months period.
Analyst established EPS growth expected to grow of 38.00% for this year and EPS growth for next year is likely to attain at 8.20%.
Looking about the past performance history, the company plunged -6.41% for the last five trades and exhausted -7.07% in one month period. The stock augmented 0.38% during the past three month period and escalated 117.36% in half year. During the yearly overview it downgraded -61.09% and shown -0.75% year to date performance.